Dr. Tracy Lively

Topic: NIH Funding Opportunities
Dr. Tracy G. Lively is the Associate Chief of the Diagnostics Evaluation Branch (DEB) of the Cancer Diagnosis Program. The DEB supports research programs to facilitate the development and validation of better diagnostic clinical tests to improve the outcomes for cancer patients. The goals are to improve the assessment of cancer prognosis by refining tumor classification and staging, predicting tumor progression and metastatic capacity, assessing the influence of germ line or somatic genetic mutations on disease prognosis, and detecting recurrence. In addition, the Branch seeks to improve the prediction and evaluation of response to treatment through development of clinically useful markers to guide the treatment of cancer patients. The Branch supports the translation of knowledge of cancer biology and tumor-host interaction from the laboratory to the clinic and the application of new biomedical technologies to prognosis and prediction through targeted initiatives, participation in broad ranging NCI and NIH initiatives, and investigator-initiated grants. CV